SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-000779
Filing Date
2022-02-14
Accepted
2022-02-14 16:00:55
Documents
70
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm   iXBRL 10-Q 1244318
2 CERTIFICATION ipix_ex311.htm EX-31.1 12767
3 CERTIFICATION ipix_ex321.htm EX-32.1 4511
  Complete submission text file 0001477932-22-000779.txt   5633188

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ipix-20211231.xsd EX-101.SCH 76156
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20211231_lab.xml EX-101.LAB 354322
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20211231_cal.xml EX-101.CAL 50355
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20211231_pre.xml EX-101.PRE 313463
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20211231_def.xml EX-101.DEF 233168
64 EXTRACTED XBRL INSTANCE DOCUMENT ipix_10q_htm.xml XML 827354
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 22631066
SIC: 2834 Pharmaceutical Preparations